You are viewing: Mexico Non Invasive Prenatal Testing Market analysis

The Mexico Non Invasive Prenatal Testing Market was valued at $63.9 Million in 2024 and projected to reach to $103.7 Million by 2029, representing a compound annual growth rate of 10.2%. Mexico's NIPT market is poised for sustained growth as healthcare modernization initiatives expand access to advanced prenatal diagnostics.

Mexico Non Invasive Prenatal Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Non Invasive Prenatal Testing Market Trends and Insights

  • This growth trajectory reflects Mexico's increasing adoption of advanced prenatal diagnostic technologies and rising healthcare investment in maternal health services.
  • Mexico's market expansion is driven by growing awareness among pregnant women, improved access to diagnostic facilities in urban centers, and rising disposable incomes enabling families to pursue non-invasive testing options. The Mexican NIPT market is characterized by a 10.2% compound annual growth rate (CAGR) over the 2024-2029 forecast period, outpacing broader regional trends.
  • Mexico's healthcare infrastructure continues to modernize, with both public and private sectors integrating NIPT into standard prenatal care protocols.
  • Key factors supporting Mexico's market growth include demographic trends favoring delayed pregnancies, increased prevalence of advanced maternal age, and strengthening regulatory frameworks that support diagnostic innovation and patient access..

Key Market Statistics

  • CAGR (2024-2029) 10.2% CAGR
  • Market Size, 2024 ~USD 63.9 Million
  • Forecast, 2029 ~USD 103.7 Million
  • Country Mexico

Mexico Non Invasive Prenatal Testing Market Overview

Market Valuation Growth :

Mexico's NIPT market is valued at USD 63.9 million in 2024, with a projected CAGR of 10.2% through 2029, reaching USD 103.7 million by forecast end.

Healthcare Investment Surge :

Rising government and private sector investment in maternal health services is accelerating NIPT adoption across Mexico's healthcare infrastructure and diagnostic centers.

Awareness and Accessibility :

Growing patient awareness of non-invasive prenatal testing benefits, combined with improved accessibility in urban and semi-urban regions, is driving market penetration in Mexico.

Technology Adoption Trend :

Mexican healthcare providers are increasingly adopting advanced prenatal diagnostic technologies, positioning NIPT as a standard offering in modern obstetric care facilities.

Mexico Non Invasive Prenatal Testing Market Dynamics

  • The 10.2% CAGR reflects Mexico's commitment to improving maternal health outcomes through technology adoption and increased healthcare spending.
  • Rising middle-class populations and enhanced insurance coverage are driving demand for non-invasive testing options. The forecast period through 2029 will see consolidation of NIPT services in major metropolitan areas, with gradual expansion into secondary cities.
  • Strategic partnerships between Mexican healthcare providers and international diagnostic companies will accelerate market development.
  • Regulatory improvements and reimbursement policies are expected to further support market expansion and accessibility across diverse socioeconomic segments..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    In Vitro Diagnostics

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Dna Microarrays
    • Assay Kits
    • Microarrays
    Top Companies
    • ROCHE HOLDINGS AG
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Abbott Laboratories
    • Biomerieux s.a.

      Key Takeaways

      • Mexico's NIPT market is valued at USD 63.9 million in 2024 and is forecast to grow to USD 103.7 million by 2029, representing a 10.2% CAGR.
      • Mexico's market growth is driven by rising maternal age, increased healthcare awareness, and expanding access to diagnostic services in both urban and emerging markets.
      • Mexico's private healthcare sector is leading NIPT adoption, while public sector integration continues to expand prenatal testing accessibility.
      • Mexico's regulatory environment and healthcare modernization initiatives are creating favorable conditions for NIPT market expansion through 2029.

      Non Invasive Prenatal Testing Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment CFDNA IN MATERNAL PLASMA (Method)
      Forecast Period 2024-2029
      Growth Rate CAGR of 14.5% from 2024 to 2029
      Largest Segment TRISOMY (Application)
      Market Size Base Year (Billions) ~USD 7.16 (2024)
      Revenue Forecast (Billions) ~USD 14.1 (2029)
      Segments Covered Product & Service, Type, Method, Application, End User

      Mexico Non Invasive Prenatal Testing Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product & Service

      • Products
      • Services

      By Type

      • Assay Kits & Reagents
      • Consumables
      • Disposables
      • Instruments
      • Microarrays
      • Ngs Systems
      • Other Instruments
      • Pcr Instruments
      • Ultrasound Devices

      By Method

      • Biochemical Screening Tests
      • Cfdna In Maternal Plasma
      • Cfdna In Maternal Plasma Tests
      • Ultrasound Detection

      By Application

      • Microdeletion Syndrome
      • Other Applications
      • Trisomy

      By End User

      • Diagnostic Laboratories
      • Hospitals

      Target Audience

      • Diagnostic Laboratory Operators : Mexican and international diagnostic labs need market intelligence to expand NIPT service offerings, optimize pricing strategies, and identify high-growth regions for facility investment.
      • Healthcare Providers & Hospitals : Obstetric clinics and maternity hospitals require data on patient demand trends, competitive offerings, and reimbursement models to integrate NIPT into their prenatal care portfolios.
      • Medical Device & IVD Manufacturers : Companies developing NIPT technologies and reagents need Mexico-specific market sizing and growth forecasts to prioritize product launches and distribution partnerships.
      • Healthcare Investors & PE Firms : Investment professionals evaluating Mexican healthcare opportunities require detailed market analysis, growth trajectories, and sector dynamics to assess NIPT investment viability.
      • Healthcare Consultants & Advisors : Strategy consultants supporting healthcare clients in Mexico need comprehensive market data to develop business plans, competitive strategies, and expansion roadmaps in prenatal diagnostics.

      Reasons to Buy this Report

      • Market Entry Strategy : Comprehensive Mexico-specific data enables informed market entry decisions, competitive positioning, and localized go-to-market strategies for NIPT service providers and diagnostic companies.
      • Investment Decision Support : Detailed market valuation, growth projections, and regional trends provide critical intelligence for investors evaluating opportunities in Mexico's expanding prenatal diagnostics sector.
      • Competitive Landscape Analysis : Understand Mexico's unique market dynamics, key players, and growth drivers to benchmark performance and identify competitive advantages in this high-growth maternal health segment.
      • Regulatory and Reimbursement Insights : Access Mexico-specific information on healthcare policies, insurance coverage, and regulatory frameworks affecting NIPT adoption and market accessibility across different regions.
      • Demand Forecasting : Leverage accurate 2024-2029 projections to forecast demand, optimize resource allocation, and plan capacity expansion for NIPT services tailored to Mexico's healthcare market.

      Frequently asked questions

      What is the current market size of NIPT in Mexico?

      Mexico's Non Invasive Prenatal Testing market was valued at USD 63.9 million in 2024 and is expected to reach USD 103.7 million by 2029.

      What is the projected growth rate for Mexico's NIPT market?

      Mexico's NIPT market is projected to grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2029.

      What factors are driving NIPT adoption in Mexico?

      Key drivers in Mexico include rising maternal age, increased healthcare awareness, improved diagnostic facility access, higher disposable incomes, and modernization of both public and private healthcare sectors.

      Which healthcare sector is leading NIPT adoption in Mexico?

      Mexico's private healthcare sector is currently leading NIPT adoption, though public sector integration is expanding to improve accessibility across the country.

      How does Mexico's NIPT market growth compare to global trends?

      Mexico's 10.2% CAGR is competitive within Latin America, driven by demographic shifts, healthcare modernization, and regulatory support for diagnostic innovation.

      RESEARCH METHODOLOGY

      This study involved four major activities in estimating the current non-invasive prenatal testing (NIPT) market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the non-invasive prenatal testing (NIPT) market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of the various companies that offer non-invasive prenatal testing (NIPT) product and service. Primary sources from the demand side include industry experts such as doctors, hospital directors and managers,  and other medical professionals.

      Primary research was conducted to identify segmentation types; industry trends; technology trends; key players; and key market dynamics such as drivers, restraints, opportunities, challenges, and key player strategies.

      Non-invasive Prenatal Testing Market Size, and Share

      Note 1: Others include sales, marketing, and product managers.

      Note 2: Their total revenues define the tiers of companies as of 2023, tier 1 = >USD 500 million, tier 2 = USD 200 million to USD 500 million, and tier 3 = <USD 200 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Non-invasive Prenatal Testing Market Size, and Share

      Market Size Estimation

      The total size of the non-invasive prenatal testing (NIPT) market was arrived at after data triangulation from four different approaches, as mentioned below.

      Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the medical device cleaning businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.

      Country level Analysis: The size of the non-invasive prenatal testing (NIPT) market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of non-invasive prenatal testing (NIPT) products in the overall non-invasive prenatal testing (NIPT) market was obtained from secondary data and validated by primary participants to arrive at the total non-invasive prenatal testing (NIPT) market. Primary participants further validated the numbers.

      Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

      Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

      Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

      Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

      At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall non-invasive prenatal testing (NIPT) market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

      After complete market engineering with calculations for market statistics, market size estimations, market forecasting, market breakdown, and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and further quantitative analysis was also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

      Global Non-invasive prenatal testing (NIPT) market Size: Top-Down Approach

      Non-invasive Prenatal Testing Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Global Non-invasive prenatal testing (NIPT) market Size: Bottom-Up Approach

      Non-invasive Prenatal Testing Market Size, and Share

      Data Triangulation

      After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable.

      Approach to derive the market size and estimate market growth

      The market rankings for leading players were ascertained after a detailed assessment of their revenues from the non-invasive prenatal testing (NIPT) business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.

      Market Definition

      Non-invasive prenatal testing (NIPT) is a method used to screen chromosomal abnormalities in a developing fetus by analyzing small fragments of fetal Cell-Free DNA circulating in a pregnant woman's blood. Non-invasive prenatal tests enable the detection of chromosomal abnormalities, such as trisomy 21 (Down Syndrome), trisomy 18 (Edwards' Syndrome), trisomy 13 (Patau Syndrome), microdeletion syndrome, and other genetic conditions. This market encompasses products such as assay kits and reagents, next generation sequencing systems, and diagnostic services offered by laboratories.

      Key Stakeholders

      • Non-invasive prenatal testing product manufacturing companies
      • Hospitals and private clinics
      • Diagnostic laboratories
      • Medical research institutes
      • Market research and consulting firms
      • Suppliers and distributors of NIPT instruments
      • Venture capitalists and investors
      • Regulatory agencies and government bodies

      Objectives of the Study

      • To define, describe, and forecast the global non-invasive prenatal testing (NIPT) market on the basis of product and service, method, application, end user, and region
      • To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
      • To strategically analyze the regulatory scenario, pricing trends, value chain, supply chain, ecosystem analysis, key stakeholders and buying criteria, technology scenario, patent scenario, and key conferences and events in the market
      • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall udder health market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
      • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies.
      • To strategically analyze the udder health market in five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
      • To track and analyze competitive developments such as acquisitions, partnerships, and expansions in the udder health market.

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

      Company Information

      • Detailed analysis and profiling of additional market players

      Geographic Analysis

      • Further breakdown of the Rest of Asia Pacific non-invasive prenatal testing (NIPT) market into China, Japan, India, South Korea, and other countries.

      Get the Full Non Invasive Prenatal Testing Market Report

      Full forecast, segment splits, and company analysis for all Non Invasive Prenatal Testing Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status